Elanco Animal Health (ELAN) Gains from Investment Securities (2017 - 2026)

Elanco Animal Health has disclosed Gains from Investment Securities across 10 years of filings, most recently posting $9.0 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $9.0 million, down 30.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.0 million (down 63.64% YoY), and the FY2025 annual result was $12.0 million, down 14.29% from the prior year.
• Gains from Investment Securities came in at $9.0 million for Q1 2026 at Elanco Animal Health, up from $2.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $14.0 million in Q4 2024 to a low of -$12.0 million in Q2 2025.
• The 5-year median for Gains from Investment Securities is $5.0 million (2024), against an average of $3.5 million.
• Across the five-year window, Gains from Investment Securities soared 500.0% in 2022 and slumped 600.0% in 2024, its largest moves.
• Elanco Animal Health's Gains from Investment Securities stood at $10.0 million in 2022, then retreated by 20.0% to $8.0 million in 2023, then surged by 75.0% to $14.0 million in 2024, then sank by 85.71% to $2.0 million in 2025, then soared by 350.0% to $9.0 million in 2026.
• The last three Gains from Investment Securities figures came in at $9.0 million (Q1 2026), $2.0 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.